Data on FDA-approved weight management medications dominate Obesity Week.

The article discusses the 2014 Obesity Week meeting, which combines both the American Society for Metabolic and Bariatric Surgery and the Obesity Society annual meetings, held in Boston, Massachusetts, on November 2-7, 2014 during which presentations were discussed focused on weight management medications. Topics discussed include approvals of naltrexone plus bupropion and liraglutide for chronic weight management, and use of lorcaserin drug for the treatment of obese patients.